Editas Medicine (EDIT) FCF Margin Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) FCF Margin Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -32,092.00 |
| Jun 30, 2025 | -116,097.00 |
| Mar 31, 2025 | -2,150.00 |
| Dec 31, 2024 | -52,471.00 |
| Sep 30, 2024 | -8.64 Mn |
| Jun 30, 2024 | -968,911.00 |
| Mar 31, 2024 | -303,672.00 |
| Dec 31, 2023 | 1,759.00 |
| Sep 30, 2023 | -61,500.00 |
| Jun 30, 2023 | -118,431.00 |
| Mar 31, 2023 | 21,937.00 |
| Sep 30, 2022 | -11.51 Mn |
| Jun 30, 2022 | -168,909.00 |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | 68,165.00 |
| Sep 30, 2021 | 139,013.00 |
| Jun 30, 2021 | -1.05 Mn |
| Mar 31, 2021 | 14,838.00 |
| Dec 31, 2020 | 48,246.00 |
| Sep 30, 2020 | 172,248.00 |